| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.33T | 8.60T | 7.86T | 4.89T | 2.84T | 2.89T |
| Gross Profit | 3.66T | 3.59T | 2.86T | 2.58T | 2.28T | 2.26T |
| EBITDA | 1.30T | 1.40T | 1.13T | 945.90B | 769.51B | 819.14B |
| Net Income | 1.01T | 885.43B | 678.99B | 555.53B | 530.48B | 471.02B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 67.29T | 10.00T> | 10.00T> | 86.46T | 70.60T | 92.46T |
| Total Debt | 60.79T | 60.89T | 58.95T | 45.34T | 40.96T | 40.31T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 11.00T | 10.44T | 10.23T | 9.13T | 9.08T | 9.26T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.17T | 326.33B | 8.68T | 4.78T | -1.57T |
| Operating Cash Flow | 0.00 | -3.82T | 389.46B | 8.87T | 4.92T | -1.46T |
| Investing Cash Flow | 0.00 | 3.79T | -9.10T | 6.61T | -1.86T | -50.54B |
| Financing Cash Flow | 0.00 | -299.03B | 12.42T | -611.14B | -522.06B | 8.57T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥3.47T | 8.79 | 9.31% | 3.31% | 16.24% | 78.76% | |
71 Outperform | $14.74T | 10.71 | 9.14% | 2.38% | -3.62% | 23.01% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥3.90T | 10.69 | 8.37% | 1.80% | 8.28% | 28.63% | |
63 Neutral | ¥8.95T | 14.35 | 5.28% | 2.73% | 2.17% | 9.55% | |
61 Neutral | ¥5.36T | 10.08 | 3.72% | 3.03% | -1.36% | 38.26% | |
54 Neutral | ¥338.89B | 10.57 | 4.74% | 3.38% | 5.47% | ― |